Liquid Handling System Market Size

The main reasons propelling the growth of the liquid handling system market are the increase in investments in drug discovery, the increase in R&D spending, the rise in the need for high-output screening, and the rise in the use of automation in clinical settings. Rising R&D initiatives for novel drug development and biotechnology research also fuel the market's expansion.

The development of vaccines and increasing investment by new drug companies are boosting the market for liquid handling systems. Manufacturers are releasing new drugs to fight disease incidence and spur market expansion. Adopting liquid handling systems that can handle high numbers of PCR tests with precise clinical results accelerates R&D and testing volume, driving market CAGR.

The Global Liquid Handling System Market Industry experiences a notable surge in demand for automation across laboratories and manufacturing sectors. Automation enhances precision and efficiency, reducing human error in liquid handling processes. As industries increasingly adopt automated solutions, the market is projected to reach 5.64 USD Billion in 2024. This trend is particularly evident in pharmaceutical and biotechnology sectors, where the need for high-throughput screening and reproducibility drives the adoption of advanced liquid handling systems. The integration of robotics and software solutions further propels this growth, indicating a shift towards more sophisticated laboratory environments.

By Region, the study provides market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Liquid Handling System market accounted for USD 14.1 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. Due to the well-established distribution networks of the key market participants and the quick uptake of advanced automation solutions, North America held the lion's market share in 2022 with a revenue share of 39.75%. The demand for small-volume genomic and proteomic analyses for life science research further fuels growth in this area.

To boost their revenue, rivals in this Region have partnered with prestigious academic institutions and research institutions in Europe.

Further, the major countries studied in the market report are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: LIQUID HANDLING SYSTEM MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Europe's liquid handling system market accounts for the second-largest market share due to the availability of cutting-edge drug development facilities, government backing for the growth of the healthcare industry, an aging population, and an increase in the adoption of advanced liquid handling solutions. Further, the Germany liquid handling system market held the largest market share, and the UK liquid handling system market was the fastest-growing market in the European Region.

The Asia-Pacific Liquid Handling System Market is expected to grow at the fastest CAGR from 2024 to 2032. The development of the biopharmaceutical industry is predicted to be aided by the rise in local biotech firms, an increase in funding assistance, the CFDA reform in China, and the price reform in Japan (affecting both off-patent and on-patent medicines). The Asia Pacific region is anticipated to grow at the quickest rate during the forecast period thanks to the quick development of biopharmaceutical and biotechnology firms, CROs, and CDMOs in nations like China and Japan.

Moreover, China's liquid handling system market held the largest market share, and the India liquid handling system market was the fastest-growing in Asia-Pacific.

Leading market players invest a lot of money in R&D to expand their product portfolios, which will spur further market growth for liquid handling system . With significant industry changes like new product releases, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations, market participants are also undertaking various strategic activities to expand their global presence. To grow and thrive in a market where competition and prices are growing, competitors in the liquid handling system sector must offer affordable products.

Manufacturing locally to cut operating costs is one of the main business tactics manufacturers use in the Liquid Handling System industry to benefit customers and develop the market sector. The liquid handling system market major player such as Agilent Technologies, Danaher Corporation,  Thermo Fisher Scientific Inc, Eppendorf AG, Tecan Group Ltd, and others are working on expanding the market demand by investing in research and development activities.

The global headquarters of the American corporation Agilent Technologies, Inc. is in Santa Clara, California. Agilent offers a broad range of technological platforms to analytical laboratories and clinical and routine diagnostics sectors. They comprise vacuum technologies, automation, bioreagents, FISH probes, gas and liquid chromatography, immunohistochemistry, informatics, mass spectrometry, microarrays, spectroscopy, target enrichment, and informatics.

In December 2022, Agilent Technologies and Fluid Management Systems (FMS), a pioneer in automated sample preparation systems, will collaborate to develop and market workflows for the testing and analysis of persistent organic pollutants (POPs), such as PFAS, Dioxins, PCBs, and other emerging contaminants in environmental and food matrices.

With its corporate headquarters in Washington, DC, the Danaher Corporation is an American multinational conglomerate. The business develops, produces, and sells industrial, commercial, professional, and medical goods and services. "Life Sciences," "Diagnostics," and "Environmental & Applied Solutions" are the three platforms used by the company. The corporation is named after the western Montana location of Danaher Creek. Mitchell Rales and Steven M. Rales, the company's founders, first had the idea while fishing there. Danaher Corporation announced in November 2022 that it had partnered strategically with Duke University to establish the first Danaher Beacon for Gene Therapy Innovation.